Form D · Biotechnology
Womens3D, Inc.
Austin, TX · CIK 0001510105
Offering snapshot reported Jan 18, 2011 · SEC filing
- Reported sold
- $25K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 16, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 18, 2011 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-153858
Source: Form D, filed Jan 18, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Dan Burck | Director |
| Mark Lenox | Director |
| Scott Sanders | Director, Executive |
| Martin Sieckmann | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4917 South Congress Avenue
Austin, TX, 78745
Austin, TX, 78745